Search filters

List of works by Sara Baglivo

Acquired Resistance to Afatinib Due to T790M-Positive Squamous Progression in EGFR-Mutant Adenosquamous Lung Carcinoma.

scientific article

Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

article

Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis.

scientific article published on 14 September 2015

Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs

scientific article published on 07 April 2020

Detection of <i>EGFR</i> Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR

scientific article published on 07 December 2020

Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation

scientific article published on 01 August 2018

Future options for ALK-positive non-small cell lung cancer.

scientific article

Identification of EML4-ALK Rearrangement and MET Exon 14 R988C Mutation in a Patient with High-Grade Neuroendocrine Lung Carcinoma Who Experienced a Lazarus Response to Crizotinib

scientific article published on 01 November 2018

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

scientific article published on 01 December 2018

Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review

scientific article published on 07 July 2020

KRAS mutation and DNA repair and synthesis genes in non-small-cell lung cancer.

scientific article

Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer

scientific article published in August 2017

Long-Lasting Response to Nivolumab and Immune-Related Adverse Events in a Nonsquamous Metastatic Non-Small Cell Lung Cancer Patient

scientific article published on 01 May 2017

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations.

scientific article

Non-coding RNAs in lung cancer

scientific article

Osimertinib

scientific article published on 01 January 2018

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

scientific article

Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib

scientific article published on 17 April 2018

Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer

scientific article published on 23 January 2019

RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature

scientific article published on 20 May 2020

Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study

scientific article published on 14 June 2017

Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression

scientific article published on 27 February 2019

Single N-glycosylation site of bovine leukemia virus SU is involved in conformation and viral escape.

scientific article

Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient

scientific article published on 01 October 2018

Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence

scientific article published on 25 April 2017

Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence

scientific article published on 04 December 2018

Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications

scientific article

The safety of nivolumab for the treatment of advanced non-small cell lung cancer

scientific article published on 02 December 2016

miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistance.

scientific article

Paulina is supported by:

About Paulina

Help